Incidental Mutation 'R4257:Gmds'
ID 321867
Institutional Source Beutler Lab
Gene Symbol Gmds
Ensembl Gene ENSMUSG00000038372
Gene Name GDP-mannose 4, 6-dehydratase
Synonyms
MMRRC Submission 041070-MU
Accession Numbers
Essential gene? Essential (E-score: 1.000) question?
Stock # R4257 (G1)
Quality Score 225
Status Validated
Chromosome 13
Chromosomal Location 32003562-32522723 bp(-) (GRCm39)
Type of Mutation missense
DNA Base Change (assembly) A to G at 32004172 bp (GRCm39)
Zygosity Heterozygous
Amino Acid Change Serine to Proline at position 337 (S337P)
Ref Sequence ENSEMBL: ENSMUSP00000036696 (fasta)
Gene Model predicted gene model for transcript(s): [ENSMUST00000041859]
AlphaFold Q8K0C9
Predicted Effect possibly damaging
Transcript: ENSMUST00000041859
AA Change: S337P

PolyPhen 2 Score 0.775 (Sensitivity: 0.85; Specificity: 0.92)
SMART Domains Protein: ENSMUSP00000036696
Gene: ENSMUSG00000038372
AA Change: S337P

DomainStartEndE-ValueType
Pfam:RmlD_sub_bind 24 229 4.3e-8 PFAM
Pfam:Epimerase 26 274 2.2e-76 PFAM
Pfam:GDP_Man_Dehyd 27 358 7.2e-167 PFAM
Meta Mutation Damage Score 0.1795 question?
Coding Region Coverage
  • 1x: 99.3%
  • 3x: 98.7%
  • 10x: 97.4%
  • 20x: 95.5%
Validation Efficiency 100% (39/39)
MGI Phenotype FUNCTION: [Summary is not available for the mouse gene. This summary is for the human ortholog.] GDP-mannose 4,6-dehydratase (GMD; EC 4.2.1.47) catalyzes the conversion of GDP-mannose to GDP-4-keto-6-deoxymannose, the first step in the synthesis of GDP-fucose from GDP-mannose, using NADP+ as a cofactor. The second and third steps of the pathway are catalyzed by a single enzyme, GDP-keto-6-deoxymannose 3,5-epimerase, 4-reductase, designated FX in humans (MIM 137020).[supplied by OMIM, Aug 2009]
Allele List at MGI
Other mutations in this stock
Total: 32 list
GeneRefVarChr/LocMutationPredicted EffectZygosity
4930451I11Rik C T 7: 126,430,662 (GRCm39) probably benign Het
4930578I06Rik C T 14: 64,210,658 (GRCm39) R190H probably benign Het
Akap13 T A 7: 75,261,033 (GRCm39) I1219K probably damaging Het
Arfgef1 T C 1: 10,229,771 (GRCm39) probably benign Het
Arhgap24 A G 5: 102,811,983 (GRCm39) E70G probably benign Het
Arsi G A 18: 61,049,723 (GRCm39) G202E probably benign Het
Babam2 T C 5: 31,859,414 (GRCm39) S40P possibly damaging Het
Brwd1 A G 16: 95,824,696 (GRCm39) V1190A probably damaging Het
Ccpg1 A G 9: 72,919,909 (GRCm39) E508G probably damaging Het
Ckm T C 7: 19,155,279 (GRCm39) S372P probably benign Het
Egflam T A 15: 7,283,907 (GRCm39) probably null Het
Farp1 G A 14: 121,492,891 (GRCm39) V498M probably benign Het
Galnt14 T A 17: 73,811,899 (GRCm39) I441F probably benign Het
Gm5414 A G 15: 101,533,107 (GRCm39) L440P probably damaging Het
Gm6563 A G 19: 23,653,339 (GRCm39) E43G possibly damaging Het
Gm9755 A T 8: 67,967,129 (GRCm39) noncoding transcript Het
L3mbtl3 T A 10: 26,156,020 (GRCm39) Q754L unknown Het
Ltk G A 2: 119,583,485 (GRCm39) T300I possibly damaging Het
Or5d46 A C 2: 88,170,621 (GRCm39) K237N probably damaging Het
Pbx2 C A 17: 34,813,619 (GRCm39) H184Q probably damaging Het
Plxna2 T C 1: 194,327,083 (GRCm39) F339S probably damaging Het
Prkaa2 A T 4: 104,897,153 (GRCm39) D353E probably benign Het
Prss36 G A 7: 127,532,010 (GRCm39) probably benign Het
Rimbp2 A G 5: 128,851,324 (GRCm39) V874A probably damaging Het
Rspo2 C A 15: 42,939,307 (GRCm39) R161L probably benign Het
Ryr1 T C 7: 28,781,875 (GRCm39) D2038G possibly damaging Het
Stkld1 A G 2: 26,833,146 (GRCm39) M111V probably benign Het
Tprn A G 2: 25,154,494 (GRCm39) I599V probably damaging Het
Upp2 A T 2: 58,670,106 (GRCm39) I219F probably damaging Het
Vmn2r94 A T 17: 18,464,433 (GRCm39) F619Y probably damaging Het
Xirp2 A G 2: 67,346,383 (GRCm39) T2875A probably benign Het
Zfp64 A G 2: 168,768,298 (GRCm39) L438P probably damaging Het
Other mutations in Gmds
AlleleSourceChrCoordTypePredicted EffectPPH Score
IGL00091:Gmds APN 13 32,418,373 (GRCm39) missense probably damaging 1.00
IGL01021:Gmds APN 13 32,311,013 (GRCm39) missense possibly damaging 0.85
IGL01463:Gmds APN 13 32,418,341 (GRCm39) missense probably damaging 1.00
IGL01780:Gmds APN 13 32,409,145 (GRCm39) nonsense probably null
IGL02570:Gmds APN 13 32,418,390 (GRCm39) splice site probably benign
IGL02944:Gmds APN 13 32,522,435 (GRCm39) missense probably benign
IGL03159:Gmds APN 13 32,003,934 (GRCm39) missense probably damaging 1.00
Insipidus UTSW 13 32,101,679 (GRCm39) missense probably benign 0.21
mini UTSW 13 32,004,172 (GRCm39) missense possibly damaging 0.77
R0114:Gmds UTSW 13 32,411,264 (GRCm39) missense probably benign 0.09
R0575:Gmds UTSW 13 32,124,566 (GRCm39) missense probably damaging 1.00
R1932:Gmds UTSW 13 32,311,980 (GRCm39) missense possibly damaging 0.87
R2516:Gmds UTSW 13 32,284,456 (GRCm39) missense probably damaging 1.00
R3877:Gmds UTSW 13 32,411,248 (GRCm39) missense probably damaging 1.00
R4380:Gmds UTSW 13 32,101,679 (GRCm39) missense probably benign 0.21
R4441:Gmds UTSW 13 32,124,461 (GRCm39) splice site probably null
R5060:Gmds UTSW 13 32,124,482 (GRCm39) missense probably benign 0.01
R5454:Gmds UTSW 13 32,312,024 (GRCm39) missense probably damaging 1.00
R5493:Gmds UTSW 13 32,124,488 (GRCm39) missense probably benign
R5571:Gmds UTSW 13 32,101,704 (GRCm39) splice site probably null
R6795:Gmds UTSW 13 32,418,335 (GRCm39) critical splice donor site probably null
R8463:Gmds UTSW 13 32,003,906 (GRCm39) missense probably benign 0.01
R9138:Gmds UTSW 13 32,311,035 (GRCm39) nonsense probably null
R9434:Gmds UTSW 13 32,284,369 (GRCm39) missense probably damaging 1.00
Predicted Primers PCR Primer
(F):5'- GATTCAGGGTGGACCGTAAG -3'
(R):5'- ACAGTTCTTACAGCAGTTCTCC -3'

Sequencing Primer
(F):5'- CGTAAGGGCGGAGTTTCTG -3'
(R):5'- AGCCATCGGAGTCACTAGG -3'
Genotyping

Genotyping is performed by amplifying the region containing the mutation using PCR, followed by sequencing of the amplified region to detect the mutation.
 

PCR Primers

R42570027_PCR_F: 5’- GATTCAGGGTGGACCGTAAG-3’

R42570027_PCR_R: 5’- ACAGTTCTTACAGCAGTTCTCC-3’

Sequencing Primers

R42570027_SEQ_F: 5’- CGTAAGGGCGGAGTTTCTG-3’
 

R42570027_SEQ_R: 5’- AGCCATCGGAGTCACTAGG-3’
 

PCR program

1) 94°C             2:00

2) 94°C             0:30

3) 55°C             0:30

4) 72°C             1:00

5) repeat steps (2-4) 40X

6) 72°C             10:00

7) 4°C               hold

The following sequence of 618 nucleotides is amplified (Chr13: 31819990-31820607; NC_000079):

gattcagggt ggaccgtaag ggcggagttt ctgccaccct ctcctataac acctcctcac       

agggccctga aaggtctcct gtttgacaac agcccgccag caagagctca cagctagcag      

ctctgagaat atgcactgga gacaaaactt acgtcaaagg caacgcgggg cttccagttt      

agcttctgct gagccttgga gcagtctccc tgcagaaagt cctgtggaga gatggcagat      

gagctgtgca tgcatgggct tgtcataccc cttgcccaat ctgtctcatc aggtacttac      

catcgggtca gctaggacct tgcaagtaag catctccaac tgcccacatt ccctgcccca      

ccttgtccta gtgactccga tggctctttc tctttctttc tttctttctt tctttctttc      

tttctttctt tctttctttc tttctttctt tctctttctt tccttccttc cttccttcct      

tccttccttc cttccttcct tccttccttc cttccttcct tctttctttc tttctttctt      

tctttctttc tttctttctt tctttctttc tttctttctt agatattaag ttgtcaggag      

aactgctgta agaactgt

Primer binding sites are underlined and the sequencing primer is highlighted; the mutated nucleotide is shown in red text (Chr. (+) = A>G).

Posted On 2015-06-20